These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1445)

  • 21. Letter: The basis for conflicting results obtained in studies on the plaque-forming cell response to type III pneumococcal polysaccharide.
    Baker PJ; Prescott B
    J Immunol; 1975 Sep; 115(3):891-2. PubMed ID: 239066
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells.
    Baker PJ; Prescott B; Stashak PW; Amsbaugh DF
    J Immunol; 1971 Sep; 107(3):719-24. PubMed ID: 4398381
    [No Abstract]   [Full Text] [Related]  

  • 23. Morphology of the antibody response to pneumococcal polysaccharide in mice.
    Hajdu I
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):226-34. PubMed ID: 43878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of amplifier T cells involved in the antibody response to the capsular polysaccharide of type III Streptococcus pneumoniae.
    Taylor CE; Stashak PW; Chiang J; Leiserson WM; Caldes G; Prescott B; Baker PJ
    J Immunol; 1984 Jun; 132(6):3103-8. PubMed ID: 6202773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary IgG responses to type III pneumococcal polysaccharide. II. Different cellular requirements for induction and elicitation.
    Braley-Mullen H
    J Immunol; 1976 Apr; 116(4):904-10. PubMed ID: 3609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the cellular immune response following in vivo immunization with pneumococcal polysaccharides in man.
    Kehrl JH; Fauci AS
    Bull Eur Physiopathol Respir; 1983; 19(2):227-34. PubMed ID: 6347283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific suppression of the antibody response in vitro by serum from paralyzed mice.
    Brown PB; Köhler H; Rowley DA
    J Immunol; 1975 Aug; 115(2):419-24. PubMed ID: 239061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of antilymphocytic antibody on the humoral immune response in different strains of mice. 3. The response to type 3 pneumococcus polysaccharide.
    Ghaffar A; James K
    Immunology; 1973 Jun; 24(6):1075-85. PubMed ID: 4146227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    Immunology; 1971 Apr; 20(4):481-92. PubMed ID: 4396489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody formation in mouse bone marrow. V. The response to the thymus-independent antigen Ecsherichia coli lipopolysaccharide.
    Benner R; van Oudenaren
    Immunology; 1976 Jan; 30(1):49-57. PubMed ID: 765265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of various adjuvants on the antibody response of mice to pneumococcal polysaccharides.
    Yin JZ; Bell MK; Thorbecke GJ
    J Biol Response Mod; 1989 Apr; 8(2):190-205. PubMed ID: 2659742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of Bordetella pertussis on the antibody response in mice to type III pneumococcal polysaccharide.
    Kong AS; Morse SI
    J Immunol; 1976 Apr; 116(4):989-93. PubMed ID: 3610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of low-dose paralysis in the absence of the ability to secrete antibody.
    Markham RB; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ
    J Immunol; 1978 Mar; 120(3):986-90. PubMed ID: 24665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory role of T cells in IgG antibody formation and immune memory to type III Pneumococcal polysaccharide.
    Braley-Mullen H
    J Immunol; 1974 Dec; 113(6):1909-20. PubMed ID: 4154347
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of cyclophosphamide on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).
    Havas HF; Schiffman G
    Cancer Res; 1981 Mar; 41(3):801-7. PubMed ID: 7459867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of two classes of antibody, gammaM and gammaG or gammaM and gammaA, by identical cells. Amplification of the antibody response to pneumococcal polysaccharide type III.
    Pasanen VJ; Asofsky R; Baker PJ
    J Exp Med; 1979 May; 149(5):1227-37. PubMed ID: 36442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvanticity of pertussis toxin is mediated by differential effects on the activity of T suppressor, T amplifier and T helper cells.
    Hasløv K; Petersen JW; Baker PJ
    Immunobiology; 1991 Sep; 183(1-2):40-54. PubMed ID: 1834545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. II. Relationship between IgM immunoglobulin levels and the ability to give an IgM antibody response.
    Amsbaugh DF; Hansen CT; Prescott B; Stashak PW; Asofsky R; Baker PJ
    J Exp Med; 1974 Jun; 139(6):1499-512. PubMed ID: 4151455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examination of the differential characteristics of amplifier and contrasuppressor T cells.
    Baker PJ; Fauntleroy MB; Prescott B
    Immunobiology; 1988 Sep; 177(4-5):438-48. PubMed ID: 2904409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen-specific suppressor T cells respond to recombinant interleukin-2 and other lymphokines.
    Taylor CE; Fauntleroy MB; Stashak PW; Baker PJ
    Infect Immun; 1991 Feb; 59(2):575-9. PubMed ID: 1824762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.